Professional Documents
Culture Documents
Web themedicalbiochemistrypage.org
Introduction
The pentose phosphate pathway is primarily an anabolic pathway that utilizes the 6
carbons of glucose to generate 5 carbon sugars and reducing equivalents. However, this
pathway does oxidize glucose and under certain conditions can completely oxidize
glucose to CO2 and water. The primary functions of this pathway are:
2. To provide the cell with ribose-5-phosphate (R5P) for the synthesis of the nucleotides
and nucleic acids.
3. Although not a significant function of the PPP, it can operate to metabolize dietary
pentose sugars derived from the digestion of nucleic acids as well as to rearrange the
carbon skeletons of dietary carbohydrates into glycolytic/gluconeogenic intermediates.
Enzymes that function primarily in the reductive direction utilize the NADP+/NADPH
cofactor pair as co-factors as opposed to oxidative enzymes that utilize the NAD+/NADH
cofactor pair. The reactions of fatty acid biosynthesis and steroid biosynthesis utilize
large amounts of NADPH. As a consequence, cells of the liver, adipose tissue, adrenal
cortex, testis and lactating mammary gland have high levels of the PPP enzymes. In fact
30% of the oxidation of glucose in the liver occurs via the PPP. Additionally,
erythrocytes utilize the reactions of the PPP to generate large amounts of NADPH used in
the reduction of glutathione (see below). The conversion of ribonucleotides to
deoxyribonucleotides (through the action of ribonucleotide reductase) requires NADPH
as the electron source, therefore, any rapidly proliferating cell needs large quantities of
NADPH.
Although the PPP operates in all cells, with high levels of expression in the above
indicated tissues, the highest levels of PPP enzymes (in particular glucose 6-phosphate
dehydrogenase) are found in neutrophils and macrophages. These leukocytes are the
phagocytic cells of the immune system and they utilize NADPH to generate superoxide
radicals from molecular oxygen in a reaction catalyzed by NADPH oxidase. Superoxide
anion, in turn, serves to generate other reactive oxygen species (ROS) the kill the
phagocytized microorganisms. Following exposure to bacteria and other foreign
substances there is a dramatic increase in O2 consumption by phagocytes. This
phenomenon is referred to as the oxygen burst.
The non-oxidative reactions of the PPP are primarily designed to generate R5P. Equally
important reactions of the PPP are to convert dietary 5 carbon sugars into both 6
(fructose-6-phosphate) and 3 (glyceraldehyde-3-phosphate) carbon sugars which can then
be utilized by the pathways of glycolysis.
The primary enzymes involved in the non-oxidative steps of the PPP are transaldolase
and transketolase:
Transketolase functions to transfer 2 carbon groups from substrates of the PPP, thus
rearranging the carbon atoms that enter this pathway. Like other enzymes that transfer 2
carbon groups, transketolase requires thiamine pyrophosphate (TPP) as a co-factor in the
transfer reaction.
The net result of the PPP, if not used solely for R5P production, is the oxidation of G6P,
a 6 carbon sugar, into a 5 carbon sugar. In turn, 3 moles of 5 carbon sugar are converted,
via the enzymes of the PPP, back into two moles of 6 carbon sugars and one mole of 3
carbon sugar. The 6 carbon sugars can be recycled into the pathway in the form of G6P,
generating more NADPH. The 3 carbon sugar generated is glyceraldehyde-3-phsphate
which can be shunted to glycolysis and oxidized to pyruvate. Alternatively, it can be
utilized by the gluconeogenic enzymes to generate more 6 carbon sugars (fructose-6-
phosphate or glucose-6-phosphate).
There are at least three inborn errors in the pentose phosphate pathway that have been
identified. The most common being the result of mutations in glucose-6-phosphate
dehydrogenase (G6PDH). Extremely rare occurrences of ribose-5-phosphate isomerase
and transaldolase deficiency have also been documented. In the transaldolase deficiency
individuals liver problems were the principal symptom in neonates. It should be clear that
any disruption in the level of NADPH may have a profound effect upon a cells ability to
deal with oxidative stress. No other cell than the erythrocyte is exposed to greater
oxidizing conditions. After all it is the oxygen carrier of the body.
Because of the need for NADPH in phagocytic cells, by the NADPH oxidase system, any
defect in enzymes in this process can result in impaired killing of infectious organisms.
Chronic granulomatous disease (CGD; also known as Bridges-Good syndrome) is a
syndrome that results in individuals harboring defects in the NADPH oxidase system.
Individuals with CGD are at increased risk for specific recurrent infections. The most
common are pneumonia, abscesses of the skin, tissues, and organs, suppurative arthritis
(invasion of the joints by infectious agent leading to generation of pus), and osteomyelitis
(infection of the bone). The majority of patients with CGD harbor mutations in a gene
that encodes a component of the NADPH oxidase system. The encoded protein is the β-
subunit of cytochrome b245 (gene symbol CYBB), also called p91-PHOX or NOX2.
However, individuals with reduced ability to produce NADPH (such as those with
G6PDH deficiencies) also manifest with CGD.
www.lef.org/Diabetes
Atherosclerosis
www.lef.org/protocols/
Atherosclerosis
CoQ10
www.lef.org/CoQ10
Supplements
www.lef.org
Arthritis
A joint-supporting, anti-
inflammatory nutrient program
for arthritis
www.lef.org/Arthritis
Omega 3
www.lef.org/Omega-3